Search

Background: Breast cancer (BC) grading plays a critical role in patient management despite the considerable inter- and intra-observer variability, highlighting the need for decision support tools to improve reproducibility and prognostic accuracy for use in clinical practice. The objective was to evaluate the ability of a digital artificial intelligence (AI) assay (PDxBr) to enrich BC grading and improve risk categorization for predicting recurrence. Methods: In our population-based longitudinal clinical development and validation study, we enrolled 2075 patients from Mount Sinai Hospital with infiltrating ductal carcinoma of the breast. With 3:1 balanced training and validation cohorts, patients were retrospectively followed for a median of 6 years. The main outcome was to validate an automated BC phenotyping system combined with clinical features to produce a binomial risk score predicting BC recurrence at diagnosis. Results: The PDxBr training model (n = 1559 patients) had a C-index of 0.78 (95% CI, 0.76–0.81) versus clinical 0.71 (95% CI, 0.67–0.74) and image feature models 0.72 (95% CI, 0.70–0.74). A risk score of 58 (scale 0–100) stratified patients as low or high risk, hazard ratio (HR) 5.5 (95% CI 4.19–7.2, p < 0.001), with a sensitivity 0.71, specificity 0.77, NPV 0.95, and PPV 0.32 for predicting BC recurrence within 6 years. In the validation cohort (n = 516), the C-index was 0.75 (95% CI, 0.72–0.79) versus clinical 0.71 (95% CI 0.66–0.75) versus image feature models 0.67 (95% CI, 0.63–071). The validation cohort had an HR of 4.4 (95% CI 2.7–7.1, p < 0.001), sensitivity of 0.60, specificity 0.77, NPV 0.94, and PPV 0.24 for predicting BC recurrence within 6 years. PDxBr also improved Oncotype Recurrence Score (RS) performance: RS 31 cutoff, C-index of 0.36 (95% CI 0.26–0.45), sensitivity 37%, specificity 48%, HR 0.48, p = 0.04 versus Oncotype RS plus AI-grade C-index 0.72 (95% CI 0.67–0.79), sensitivity 78%, specificity 49%, HR 4.6, p < 0.001 versus Oncotype RS plus PDxBr, C-index 0.76 (95% CI 0.70–0.82), sensitivity 67%, specificity 80%, HR 6.1, p < 0.001. Conclusions: PDxBr is a digital BC test combining automated AI-BC prognostic grade with clinical–pathologic features to predict the risk of early-stage BC recurrence. With future validation studies, we anticipate the PDxBr model will enrich current gene expression assays and enhance treatment decision-making. [ABSTRACT FROM AUTHOR]

Institutions of higher education are facing a "mental health crisis. "Students are experiencing high rates of mental health issues, exacerbated by the pandemic. At the same time, the severity of psychological disorders is accelerating among students. These developments have put enormous pressure on traditional university support systems, and schools have turned to new technologies, like online mental health resources and monitoring systems using artificial intelligence, to expand their mental health services. This article explores the liability implications of using these emerging technologies to address these escalating needs. Universities offer mental health services in good faith to help their students succeed, and these emerging technologies potentially offer significant advantages toward meeting that goal. Tort law should not deter adoption of new technologies, but it is critical to recognize that their adoption may expand exposure to liability. Despite this paradox, use of these technologies is here, and universities need to consider their implementation. [ABSTRACT FROM AUTHOR]

The World Health Organization (WHO), in their 2022 report, identified cancer as one of the leading causes of death, accounting for about 16% of deaths worldwide. The Cancer-Moonshot community aims to reduce the cancer death rate by half in the next 25 years and wants to improve the lives of cancer-affected people. Cancer mortality can be reduced if detected early and treated appropriately. Cancers like breast cancer and cervical cancer have high cure probabilities when treated early in accordance with best practices. Integration of artificial intelligence (AI) into cancer research is currently addressing many of the challenges where medical experts fail to bring cancer to control and cure, and the outcomes are quite encouraging. AI offers many tools and platforms to facilitate more understanding and tackling of this life-threatening disease. AI-based systems can help pathologists in diagnosing cancer more accurately and consistently, reducing the case error rates. Predictive-AI models can estimate the likelihood for a person to get cancer by identifying the risk factors. Big data, together with AI, can enable medical experts to develop customized treatments for cancer patients. The side effects from this kind of customized therapy will be less severe in comparison with the generalized therapies. However, many of these AI tools will remain ineffective in fighting against cancer and saving the lives of millions of patients unless they are accessible and understandable to biologists, oncologists, and other medical cancer researchers. This paper presents the trends, challenges, and future directions of AI in cancer research. We hope that this paper will be of help to both medical experts and technical experts in getting a better understanding of the challenges and research opportunities in cancer diagnosis and treatment. [ABSTRACT FROM AUTHOR]

Healthcare sector stocks are a very good opportunity for investors to obtain gains faster most of the time in a year and mostly during this COVID pandemic. Purchasing a healthcare stock of a certain company indicates that you hold a part of the company shares. Specifically, various examinations have been led to anticipate the development of financial exchange utilizing AI calculations, such as SVM and reinforcement learning. A collection of machine learning algorithms are executed on Indian stock price data to precisely come up with the value of the stock in the future. Experiments are performed to find such healthcare sector stock markets that are difficult to predict and those that are more influenced by social media and financial news. The impact of sentiments on predicting stock prices is displayed and the accuracy of the final model is further increased by incorporating sentiment analysis. [ABSTRACT FROM AUTHOR]

Artificial intelligence (AI) will change the face of nuclear medicine and molecular imaging as it will in everyday life. In this review, we focus on the potential applications of AI in the field, both from a physical (radiomics, underlying statistics, image reconstruction and data analysis) and a clinical (neurology, cardiology, oncology) perspective. Challenges for transferability from research to clinical practice are being discussed as is the concept of explainable AI. Finally, we focus on the fields where challenges should be set out to introduce AI in the field of nuclear medicine and molecular imaging in a reliable manner. [ABSTRACT FROM AUTHOR]

Prostate cancer represents one of the most common malignant tumors in male patients in Germany. The pathological reporting of radical prostatectomy specimens following a structured process constitutes an excellent prototype for the introduction of software-based standardized structured reporting in pathology. This can lead to reports of higher quality and could create a fundamental improvement for future AI applications. A software-based reporting template was used to generate standardized structured pathological reports of radical prostatectomy specimens of patients treated at the University Hospital Klinikum rechts der Isar of Technische Universität München, Germany. Narrative reports (NR) and standardized structured reports (SSR) were analyzed with regard to completeness, and clinicians' satisfaction with each report type was evaluated. SSR show considerably higher completeness than NR. A total of 10 categories out of 32 were significantly more complete in SSR than in NR (p < 0.05). Clinicians awarded overall high scores in NR and SSR reports. One rater acknowledged a significantly higher level of clarity and time saving when comparing SSR to NR. Our findings highlight that the standardized structured reporting of radical prostatectomy specimens, qualifying as level 5 reports, significantly increases objectively measured content quality and the level of completeness. The implementation of nationwide SSR in Germany, particularly in oncologic pathology, can serve pathologists, clinicians, and patients. [ABSTRACT FROM AUTHOR]

Purpose: Artificial neural networks, "artificial intelligence" or machine learning now dominate a number of areas, making many activities automatic and thus affecting the safety and comfort of life. Neural networks might provide intelligent decisions with limited human assistance. Medicine also uses artificial intelligence, also in models designed to support the therapeutic process. The aim of this article is to define the main directions of development of machine learning applications in supporting the therapeutic processes. Views: Currently, the literature distinguishes at least a few applications of new technologies of varying degrees of advancement, with machine learning at the forefront [6]. It seems that the researchers are most interested in personalizing notifications of therapeutic applications, modifying therapeutic programs in a manner adapted to the patient's problems, and conducting "intelligent" conversations with them. Conclusions: There are dangers in using machine learning methods to support the therapeutic process. Particular attention should be paid to ensuring the full privacy of the implemented applications; moreover, selling user data of this type to third parties, such as those that sell certain medications or dietary supplements, would be ethically questionable. There are no legal regulations (or a system of recommendations of relevant scientific societies) that would limit proven applications to support the therapeutic process of a given disorder in the future, and which were created solely for the financial purpose of authors who did not conduct substantive consultations. [ABSTRACT FROM AUTHOR]

Background: Given the rapidity with which artificial intelligence is gaining momentum in clinical medicine, current physician leaders have called for more incorporation of artificial intelligence topics into undergraduate medical education. This is to prepare future physicians to better work together with artificial intelligence technology. However, the first step in curriculum development is to survey the needs of end users. There has not been a study to determine which media and which topics are most preferred by US medical students to learn about the topic of artificial intelligence in medicine. Objective: We aimed to survey US medical students on the need to incorporate artificial intelligence in undergraduate medical education and their preferred means to do so to assist with future education initiatives. Methods: A mixed methods survey comprising both specific questions and a write-in response section was sent through Qualtrics to US medical students in May 2021. Likert scale questions were used to first assess various perceptions of artificial intelligence in medicine. Specific questions were posed regarding learning format and topics in artificial intelligence. Results: We surveyed 390 US medical students with an average age of 26 (SD 3) years from 17 different medical programs (the estimated response rate was 3.5%). A majority (355/388, 91.5%) of respondents agreed that training in artificial intelligence concepts during medical school would be useful for their future. While 79.4% (308/388) were excited to use artificial intelligence technologies, 91.2% (353/387) either reported that their medical schools did not offer resources or were unsure if they did so. Short lectures (264/378, 69.8%), formal electives (180/378, 47.6%), and Q and A panels (167/378, 44.2%) were identified as preferred formats, while fundamental concepts of artificial intelligence (247/379, 65.2%), when to use artificial intelligence in medicine (227/379, 59.9%), and pros and cons of using artificial intelligence (224/379, 59.1%) were the most preferred topics for enhancing their training. Conclusions: The results of this study indicate that current US medical students recognize the importance of artificial intelligence in medicine and acknowledge that current formal education and resources to study artificial intelligence–related topics are limited in most US medical schools. Respondents also indicated that a hybrid formal/flexible format would be most appropriate for incorporating artificial intelligence as a topic in US medical schools. Based on these data, we conclude that there is a definitive knowledge gap in artificial intelligence education within current medical education in the US. Further, the results suggest there is a disparity in opinions on the specific format and topics to be introduced. [ABSTRACT FROM AUTHOR]

Background: Home blood pressure (BP) monitoring is recommended for people with hypertension; however, meta-analyses have demonstrated that BP improvements are related to additional coaching support in combination with self-monitoring, with little or no effect of self-monitoring alone. High-contact coaching requires substantial resources and may be difficult to deliver via human coaching models. Objective: This observational study assessed changes in BP and body weight following participation in a fully digital program called Lark Hypertension Care with coaching powered by artificial intelligence (AI). Methods: Participants (N=864) had a baseline systolic BP (SBP) ≥120 mm Hg, provided their baseline body weight, and had reached at least their third month in the program. The primary outcome was the change in SBP at 3 and 6 months, with secondary outcomes of change in body weight and associations of changes in SBP and body weight with participant demographics, characteristics, and program engagement. Results: By month 3, there was a significant drop of -5.4 mm Hg (95% CI -6.5 to -4.3; P<.001) in mean SBP from baseline. BP did not change significantly (ie, the SBP drop maintained) from 3 to 6 months for participants who provided readings at both time points (P=.49). Half of the participants achieved a clinically meaningful drop of ≥5 mm Hg by month 3 (178/349, 51.0%) and month 6 (98/199, 49.2%). The magnitude of the drop depended on starting SBP. Participants classified as hypertension stage 2 had the largest mean drop in SBP of -12.4 mm Hg (SE 1.2 mm Hg) by month 3 and -13.0 mm Hg (SE 1.6 mm Hg) by month 6; participants classified as hypertension stage 1 lowered by -5.2 mm Hg (SE 0.8) mm Hg by month 3 and -7.3 mm Hg (SE 1.3 mm Hg) by month 6; participants classified as elevated lowered by -1.1 mm Hg (SE 0.7 mm Hg) by month 3 but did not drop by month 6. Starting SBP (β=.11; P<.001), percent weight change (β=-.36; P=.02), and initial BMI (β=-.56; P<.001) were significantly associated with the likelihood of lowering SBP ≥5 mm Hg by month 3. Percent weight change acted as a mediator of the relationship between program engagement and drop in SBP. The bootstrapped unstandardized indirect effect was -0.0024 (95% CI -0.0052 to 0; P=.002). Conclusions: A hypertension care program with coaching powered by AI was associated with a clinically meaningful reduction in SBP following 3 and 6 months of program participation. Percent weight change was significantly associated with the likelihood of achieving a ≥5 mm Hg drop in SBP. An AI-powered solution may offer a scalable approach to helping individuals with hypertension achieve clinically meaningful reductions in their BP and associated risk of cardiovascular disease and other serious adverse outcomes via healthy lifestyle changes such as weight loss. [ABSTRACT FROM AUTHOR]

Background: Mobile technologies are being increasingly developed to support the practice of medicine, nursing, and public health, including HIV testing and prevention. Chatbots using artificial intelligence (AI) are novel mobile health strategies that can promote HIV testing and prevention among men who have sex with men (MSM) in Malaysia, a hard-to-reach population at elevated risk of HIV, yet little is known about the features that are important to this key population. Objective: The aim of this study was to identify the barriers to and facilitators of Malaysian MSM's acceptance of an AI chatbot designed to assist in HIV testing and prevention in relation to its perceived benefits, limitations, and preferred features among potential users. Methods: We conducted 5 structured web-based focus group interviews with 31 MSM in Malaysia between July 2021 and September 2021. The interviews were first recorded, transcribed, coded, and thematically analyzed using NVivo (version 9; QSR International). Subsequently, the unified theory of acceptance and use of technology was used to guide data analysis to map emerging themes related to the barriers to and facilitators of chatbot acceptance onto its 4 domains: performance expectancy, effort expectancy, facilitating conditions, and social influence. Results: Multiple barriers and facilitators influencing MSM's acceptance of an AI chatbot were identified for each domain. Performance expectancy (ie, the perceived usefulness of the AI chatbot) was influenced by MSM's concerns about the AI chatbot's ability to deliver accurate information, its effectiveness in information dissemination and problem-solving, and its ability to provide emotional support and raise health awareness. Convenience, cost, and technical errors influenced the AI chatbot's effort expectancy (ie, the perceived ease of use). Efficient linkage to health care professionals and HIV self-testing was reported as a facilitating condition of MSM's receptiveness to using an AI chatbot to access HIV testing. Participants stated that social influence (ie, sociopolitical climate) factors influencing the acceptance of mobile technology that addressed HIV in Malaysia included privacy concerns, pervasive stigma against homosexuality, and the criminalization of same-sex sexual behaviors. Key design strategies that could enhance MSM's acceptance of an HIV prevention AI chatbot included an anonymous user setting; embedding the chatbot in MSM-friendly web-based platforms; and providing user-guiding questions and options related to HIV testing, prevention, and treatment. Conclusions: This study provides important insights into key features and potential implementation strategies central to designing an AI chatbot as a culturally sensitive digital health tool to prevent stigmatized health conditions in vulnerable and systematically marginalized populations. Such features not only are crucial to designing effective user-centered and culturally situated mobile health interventions for MSM in Malaysia but also illuminate the importance of incorporating social stigma considerations into health technology implementation strategies. [ABSTRACT FROM AUTHOR]

Background: Coronavirus continues to spread worldwide, causing various health and economic disruptions. One of the most important approaches to controlling the spread of this disease is to use an artificial intelligence (AI)-based technological intervention, such as a chatbot system. Chatbots can aid in the fight against the spread of COVID-19. Objective: This paper introduces COVID-Bot, an intelligent interactive system that can help screen students and confirm their COVID-19 vaccination status. Methods: The design and development of COVID-Bot followed the principles of the design science research (DSR) process, which is a research method for creating a new scientific artifact. COVID-Bot was developed and implemented using the SnatchBot chatbot application programming interface (API) and its predefined tools, which are driven by various natural language processing algorithms. Results: An evaluation was carried out through a survey that involved 106 university students in determining the functionality, compatibility, reliability, and usability of COVID-Bot. The findings indicated that 92 (86.8%) of the participants agreed that the chatbot functions well, 85 (80.2%) agreed that it fits well with their mobile devices and their lifestyle, 86 (81.1%) agreed that it has the potential to produce accurate and consistent responses, and 85 (80.2%) agreed that it is easy to use. The average obtained α was .87, indicating satisfactory reliability. Conclusions: This study demonstrates that incorporating chatbot technology into the educational system can combat the spread of COVID-19 among university students. The intelligent system does this by interacting with students to determine their vaccination status. [ABSTRACT FROM AUTHOR]

This article presents an overview of deep learning (DL) and its applications to function approximation for MR in medicine. The aim of this article is to help readers develop various applications of DL. DL has made a large impact on the literature of many medical sciences, including MR. However, its technical details are not easily understandable for non-experts of machine learning (ML). The first part of this article presents an overview of DL and its related technologies, such as artificial intelligence (AI) and ML. AI is explained as a function that can receive many inputs and produce many outputs. ML is a process of fitting the function to training data. DL is a kind of ML, which uses a composite of many functions to approximate the function of interest. This composite function is called a deep neural network (DNN), and the functions composited into a DNN are called layers. This first part also covers the underlying technologies required for DL, such as loss functions, optimization, initialization, linear layers, non-linearities, normalization, recurrent neural networks, regularization, data augmentation, residual connections, autoencoders, generative adversarial networks, model and data sizes, and complex-valued neural networks. The second part of this article presents an overview of the applications of DL in MR and explains how functions represented as DNNs are applied to various applications, such as RF pulse, pulse sequence, reconstruction, motion correction, spectroscopy, parameter mapping, image synthesis, and segmentation. [ABSTRACT FROM AUTHOR]

The recent Coronavirus disease 2019 (COVID-19) pandemic displayed weaknesses in the healthcare infrastructures worldwide and exposed a lack of specialized personnel to cover the demands of a massive calamity. We have developed a portable ventilator that uses real-time vitals read from the patient to estimate -- through artificial intelligence -- the optimal operation point. The ventilator has redundant telecommunication capabilities; therefore, the remote assistance model can protect specialists and relatives from highly contagious agents. Additionally, we have designed a system that automatically publishes information in a proprietary cloud centralizer to keep physicians and relatives informed. The system was tested in a residential last-mile connection, and transaction times below the second were registered. The timing scheme allows us to operate up to 200 devices concurrently on these lowest-specification transmission control protocol/internet protocol (TCP/IP) services, promptly transmitting data for online processing and reporting. The ventilator is a proof of concept of automation that has behavioral and cognitive inputs to cheaply, yet reliably, extend the installed capacity of the healthcare systems and multiply the response of the skilled medical personnel to cover high-demanding scenarios and improve service quality.

Background: Recent studies, including those by the National Board of Medical Examiners, have highlighted the remarkable capabilities of recent large language models (LLMs) such as ChatGPT in passing the United States Medical Licensing Examination (USMLE). However, there is a gap in detailed analysis of LLM performance in specific medical content areas, thus limiting an assessment of their potential utility in medical education., Objective: This study aimed to assess and compare the accuracy of successive ChatGPT versions (GPT-3.5, GPT-4, and GPT-4 Omni) in USMLE disciplines, clinical clerkships, and the clinical skills of diagnostics and management., Methods: This study used 750 clinical vignette-based multiple-choice questions to characterize the performance of successive ChatGPT versions (ChatGPT 3.5 [GPT-3.5], ChatGPT 4 [GPT-4], and ChatGPT 4 Omni [GPT-4o]) across USMLE disciplines, clinical clerkships, and in clinical skills (diagnostics and management). Accuracy was assessed using a standardized protocol, with statistical analyses conducted to compare the models' performances., Results: GPT-4o achieved the highest accuracy across 750 multiple-choice questions at 90.4%, outperforming GPT-4 and GPT-3.5, which scored 81.1% and 60.0%, respectively. GPT-4o's highest performances were in social sciences (95.5%), behavioral and neuroscience (94.2%), and pharmacology (93.2%). In clinical skills, GPT-4o's diagnostic accuracy was 92.7% and management accuracy was 88.8%, significantly higher than its predecessors. Notably, both GPT-4o and GPT-4 significantly outperformed the medical student average accuracy of 59.3% (95% CI 58.3-60.3)., Conclusions: GPT-4o's performance in USMLE disciplines, clinical clerkships, and clinical skills indicates substantial improvements over its predecessors, suggesting significant potential for the use of this technology as an educational aid for medical students. These findings underscore the need for careful consideration when integrating LLMs into medical education, emphasizing the importance of structured curricula to guide their appropriate use and the need for ongoing critical analyses to ensure their reliability and effectiveness., (© Brenton T Bicknell, Danner Butler, Sydney Whalen, James Ricks, Cory J Dixon, Abigail B Clark, Olivia Spaedy, Adam Skelton, Neel Edupuganti, Lance Dzubinski, Hudson Tate, Garrett Dyess, Brenessa Lindeman, Lisa Soleymani Lehmann. Originally published in JMIR Medical Education (https://mededu.jmir.org).)

Abstract Background In the development of artificial intelligence in ophthalmology, the ophthalmic AI-related recognition issues are prominent, but there is a lack of research into people’s familiarity with and their attitudes toward ophthalmic AI. This survey aims to assess medical workers’ and other professional technicians’ familiarity with, attitudes toward, and concerns about AI in ophthalmology. Methods This is a cross-sectional study design study. An electronic questionnaire was designed through the app Questionnaire Star, and was sent to respondents through WeChat, China’s version of Facebook or WhatsApp. The participation was voluntary and anonymous. The questionnaire consisted of four parts, namely the respondents’ background, their basic understanding of AI, their attitudes toward AI, and their concerns about AI. A total of 562 respondents were counted, with 562 valid questionnaires returned. The results of the questionnaires are displayed in an Excel 2003 form. Results There were 291 medical workers and 271 other professional technicians completed the questionnaire. About 1/3 of the respondents understood AI and ophthalmic AI. The percentages of people who understood ophthalmic AI among medical workers and other professional technicians were about 42.6 % and 15.6 %, respectively. About 66.0 % of the respondents thought that AI in ophthalmology would partly replace doctors, about 59.07 % having a relatively high acceptance level of ophthalmic AI. Meanwhile, among those with AI in ophthalmology application experiences (30.6 %), above 70 % of respondents held a full acceptance attitude toward AI in ophthalmology. The respondents expressed medical ethics concerns about AI in ophthalmology. And among the respondents who understood AI in ophthalmology, almost all the people said that there was a need to increase the study of medical ethics issues in the ophthalmic AI field. Conclusions The survey results revealed that the medical workers had a higher understanding level of AI in ophthalmology than other professional technicians, making it necessary to popularize ophthalmic AI education among other professional technicians. Most of the respondents did not have any experience in ophthalmic AI but generally had a relatively high acceptance level of AI in ophthalmology, and there was a need to strengthen research into medical ethics issues.

The recent Coronavirus disease 2019 (COVID-19) pandemic displayed weaknesses in the healthcare infrastructures worldwide and exposed a lack of specialized personnel to cover the demands of a massive calamity. We have developed a portable ventilator that uses real-time vitals read from the patient to estimate -- through artificial intelligence -- the optimal operation point. The ventilator has redundant telecommunication capabilities; therefore, the remote assistance model can protect specialists and relatives from highly contagious agents. Additionally, we have designed a system that automatically publishes information in a proprietary cloud centralizer to keep physicians and relatives informed. The system was tested in a residential last-mile connection, and transaction times below the second were registered. The timing scheme allows us to operate up to 200 devices concurrently on these lowest-specification transmission control protocol/internet protocol (TCP/IP) services, promptly transmitting data for online processing and reporting. The ventilator is a proof of concept of automation that has behavioral and cognitive inputs to cheaply, yet reliably, extend the installed capacity of the healthcare systems and multiply the response of the skilled medical personnel to cover high-demanding scenarios and improve service quality.

The combination of "Big Data" and Artificial Intelligence (AI) is frequently promoted as having the potential to deliver valuable health benefits when applied to medical decision-making. However, the responsible adoption of AI-based clinical decision support systems faces several challenges at both the individual and societal level. One of the features that has given rise to particular concern is the issue of explainability, since, if the way an algorithm arrived at a particular output is not known (or knowable) to a physician, this may lead to multiple challenges, including an inability to evaluate the merits of the output. This "opacity" problem has led to questions about whether physicians are justified in relying on the algorithmic output, with some scholars insisting on the centrality of explainability, while others see no reason to require of AI that which is not required of physicians. We consider that there is merit in both views but find that greater nuance is necessary in order to elucidate the underlying function of explainability in clinical practice and, therefore, its relevance in the context of AI for clinical use. In this paper, we explore explainability by examining what it requires in clinical medicine and draw a distinction between the function of explainability for the current patient versus the future patient. This distinction has implications for what explainability requires in the short and long term. We highlight the role of transparency in explainability, and identify semantic transparency as fundamental to the issue of explainability itself. We argue that, in day-to-day clinical practice, accuracy is sufficient as an "epistemic warrant" for clinical decision-making, and that the most compelling reason for requiring explainability in the sense of scientific or causal explanation is the potential for improving future care by building a more robust model of the world. We identify the goal of clinical decision-making as being to deliver the best possible outcome as often as possible, and find--that accuracy is sufficient justification for intervention for today's patient, as long as efforts to uncover scientific explanations continue to improve healthcare for future patients. [ABSTRACT FROM AUTHOR]

Copyright of Journal of Ankara University Faculty of Medicine / Ankara Üniversitesi Tip Fakültesi Mecmuasi is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Skin diseases remains a significant medical problem. It is associated with increasing prevalence, morbidity, and relapses, as well as development of complications, which has a negative impact on the patient’s quality of life. The approach to the diagnosis and treatment of dermatological diseases has changed significantly with the development of information technology. Algorithms of artificial intelligence are developed to assist dermatologists with the diagnosis of diseases. They may facilitate early diagnosis and reduce the number of appointments, reduce the waiting time for specialist consultations and the correct distribution of patient referrals to doctors of other specialties. This article focuses on this developing field of knowledge. [ABSTRACT FROM AUTHOR]

The subject of artificial intelligence (AI) has experienced magnificent development and growth over the past two decades. AI has gained amazing application in various fields including dentistry. AI is swiftly gaining the consideration of researchers around the world. The main benefit of AI is that it is based on natural language model and has become most convincing where readers can't even distinguish if it is a human written or system written. AI, which mimics human cognitive functions, is a forward leap in innovation, and has fascinated the minds of scientists over the globe. Dentists can use AI to guarantee better health-care result, quality therapy, and accomplish accuracy. AI can assist with anticipating the letdowns in clinical scenarios and illustrate dependable solutions. [ABSTRACT FROM AUTHOR]

Background: The Extension for Community Health Outcomes (ECHO) Autism Program trains clinicians to screen, diagnose, and care for children with autism spectrum disorder (ASD) in primary care settings. This study will assess the feasibility and impact of integrating an artificial intelligence (AI)-based ASD diagnosis aid (the device) into the existing ECHO Autism Screening Tool for Autism in Toddlers and Young Children (STAT) diagnosis model. The prescription-only Software as a Medical Device, designed for use in children aged 18 to 72 months at risk for developmental delay, produces ASD diagnostic recommendations after analyzing behavioral features from 3 distinct inputs: a caregiver questionnaire, 2 short home videos analyzed by trained video analysts, and a health care provider questionnaire. The device is not a stand-alone diagnostic and should be used in conjunction with clinical judgment. Objective: This study aims to assess the feasibility and impact of integrating an AI-based ASD diagnosis aid into the ECHO Autism STAT diagnosis model. The time from initial ECHO Autism clinician concern to ASD diagnosis is the primary end point. Secondary end points include the time from initial caregiver concern to ASD diagnosis, time from diagnosis to treatment initiation, and clinician and caregiver experience of device use as part of the ASD diagnostic journey. Methods: Research participants for this prospective observational study will be patients suspected of having ASD (aged 18-72 months) and their caregivers and up to 15 trained ECHO Autism clinicians recruited by the ECHO Autism Communities research team from across rural and suburban areas of the United States. Clinicians will provide routine clinical care and conduct best practice ECHO Autism diagnostic evaluations in addition to prescribing the device. Outcome data will be collected via a combination of electronic questionnaires, reviews of standard clinical care records, and analysis of device outputs. The expected study duration is no more than 12 months. The study was approved by the institutional review board of the University of Missouri-Columbia (institutional review board-assigned project number 2075722). Results: Participant recruitment began in April 2022. As of June 2022, a total of 41 participants have been enrolled. Conclusions: This prospective observational study will be the first to evaluate the use of a novel AI-based ASD diagnosis aid as part of a real-world primary care diagnostic pathway. If device integration into primary care proves feasible and efficacious, prolonged delays between the first ASD concern and eventual diagnosis may be reduced. Streamlining primary care ASD diagnosis could potentially reduce the strain on specialty services and allow a greater proportion of children to commence early intervention during a critical neurodevelopmental window. [ABSTRACT FROM AUTHOR]

Background: Patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) are self-reporting tools that can measure important information about patients, such as health priorities, experience, and perception of outcome. The use of traditional objective measures such as vital signs and lab values can be supplemented with these self-reported patient measures to provide a more complete picture of a patient's health status. Machine learning, the use of computer algorithms that improve automatically through experience, is a powerful tool in health care that often does not use subjective information shared by patients. However, machine learning has largely been based on objective measures and has been developed without patient or public input. Algorithms often do not have access to critical information from patients and may be missing priorities and measures that matter to patients. Combining objective measures with patient-reported measures can improve the ability of machine learning algorithms to assess patients' health status and improve the delivery of health care. Objective: The objective of this scoping review is to identify gaps and benefits in the way machine learning is integrated with patient-reported outcomes for the development of improved public and patient partnerships in research and health care. Methods: We reviewed the following 3 questions to learn from existing literature about the reported gaps and best methods for combining machine learning and patient-reported outcomes: (1) How are the public engaged as involved partners in the development of artificial intelligence in medicine (2) What examples of good practice can we identify for the integration of PROMs into machine learning algorithms (3) How has value-based health care influenced the development of artificial intelligence in health care We searched Ovid MEDLINE(R), Embase, PsycINFO, Science Citation Index, Cochrane Library, and Database of Abstracts of Reviews of Effects in addition to PROSPERO and the ClinicalTrials website. The authors will use Covidence to screen titles and abstracts and to conduct the review. We will include systematic reviews and overviews published in any language and may explore additional study types. Quantitative, qualitative, and mixed methods studies are included in the reviews. Results: The search is completed, and Covidence software will be used to work collaboratively. We will report the review using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and Critical Appraisal Skills Programme for systematic reviews. Conclusions: Findings from our review will help us identify examples of good practice for how to involve the public in the development of machine learning systems as well as interventions and outcomes that have used PROMs and PREMs. [ABSTRACT FROM AUTHOR]

Cardiovascular disease (CVD) represents a significant and increasing burden on healthcare systems. Artificial intelligence (AI) is a rapidly evolving transdisciplinary field employing machine learning (ML) techniques, which aim to simulate human intuition to offer cost-effective and scalable solutions to better manage CVD. ML algorithms are increasingly being developed and applied in various facets of cardiovascular medicine, including and not limited to heart failure, electrophysiology, valvular heart disease and coronary artery disease. Within heart failure, AI algorithms can augment diagnostic capabilities and clinical decision-making through automated cardiac measurements. Occult cardiac disease is increasingly being identified using ML from diagnostic data. Improved diagnostic and prognostic capabilities using ML algorithms are enhancing clinical care of patients with valvular heart disease and coronary artery disease. The growth of AI techniques is not without inherent challenges, most important of which is the need for greater external validation through multicenter, prospective clinical trials. [ABSTRACT FROM AUTHOR]

The combination of “Big Data” and Artificial Intelligence (AI) is frequently promoted as having the potential to deliver valuable health benefits when applied to medical decision-making. However, the responsible adoption of AI-based clinical decision support systems faces several challenges at both the individual and societal level. One of the features that has given rise to particular concern is the issue of explainability, since, if the way an algorithm arrived at a particular output is not known (or knowable) to a physician, this may lead to multiple challenges, including an inability to evaluate the merits of the output. This “opacity” problem has led to questions about whether physicians are justified in relying on the algorithmic output, with some scholars insisting on the centrality of explainability, while others see no reason to require of AI that which is not required of physicians. We consider that there is merit in both views but find that greater nuance is necessary in order to elucidate the underlying function of explainability in clinical practice and, therefore, its relevance in the context of AI for clinical use. In this paper, we explore explainability by examining what it requires in clinical medicine and draw a distinction between the function of explainability for the current patient versus the future patient. This distinction has implications for what explainability requires in the short and long term. We highlight the role of transparency in explainability, and identify semantic transparency as fundamental to the issue of explainability itself. We argue that, in day-to-day clinical practice, accuracy is sufficient as an “epistemic warrant” for clinical decision-making, and that the most compelling reason for requiring explainability in the sense of scientific or causal explanation is the potential for improving future care by building a more robust model of the world. We identify the goal of clinical decision-making as being to deliver the best possible outcome as often as possible, and find—that accuracy is sufficient justification for intervention for today’s patient, as long as efforts to uncover scientific explanations continue to improve healthcare for future patients.

Artificial intelligence (AI) is revolutionizing pathology by enhancing diagnostic accuracy and efficiency. AI integration in pathology addresses interobserver variability, ensuring consistent and rapid processing of pathology specimens. Beyond diagnosis, AI predicts prognosis and patient outcomes, showing superior performance in various studies. For instance, AI has improved cancer detection accuracy by 7.3%, especially in small specimens, and in prostate cancer, AI algorithms match or exceed the diagnostic capabilities of senior pathologists, reducing the need for second opinions by up to 40%. In gastrointestinal diseases, AI achieves the same accuracy as pathologists in complex biopsy analyses. Additionally, AI-assisted immunohistochemistry staining shows a high correlation with pathologist scoring, with Spearman correlation coefficients of 0.88 and 0.90. AI's accuracy in diagnosing and classifying brain tumors reaches up to 88%, and in screening cervical cancer using whole slide images, AI attains 93.5% specificity and 95.1% sensitivity compared to trained pathologists. Despite these advancements, challenges remain in the clinical implementation of AI in pathology. The need for large datasets and storage space poses financial challenges for institutions. Data privacy, comprehensive validation, and avoiding over-reliance on automated systems are crucial to addressing ethical concerns. Ongoing education and training for medical staff are essential for effective adaptation to AI technologies. As AI evolves, it promises to significantly impact pathological services, leading to improved patient care and outcomes and reducing diagnostic times. The future of AI in pathology is promising, contingent on overcoming these challenges in the coming years. [ABSTRACT FROM AUTHOR]

Non-small cell lung cancer (NSCLC), the most common subtype of lung cancer, accounts for approximately 85% of all cases. Significant advances are being made in the diagnosis and treatment of NSCLC, especially with the help of molecular translational research. Programmed cell death ligand 1 (PD-L1) is an important cell surface protein that plays a central role in many types of cancer. It is considered the gold standard predictive biomarker for immunotherapy selection in advanced NSCLC patients. In clinical studies, protein profiling and immunofluorescence methods are promising for routine PD-L1-related tests and advances in this field have been accelerating with the help of artificial intelligence (AI). Machine learning (ML), a subset of AI, is defined as a method of analyzing sample data with a target task, parsing this data into predictive models and clustering it on its own, and then analyzing it by the computer. As the most used method for predicting efficiency and analyzing multi-omics data, ML has been one of the promising developments in evidence-based medicine. Many prediction models based on ML algorithms are used today due to the development and widespread use of digital images. Research shows that AI has made progress in early diagnosis and screening of NSCLC and in evaluating immunotherapy effectiveness and prognosis. It is anticipated that future research and AI methods will advance the diagnosis and treatment of NSCLC even with a single marker. [ABSTRACT FROM AUTHOR]

Hematologic malignancies are cancerous diseases that affect the blood and blood-forming organs, such as leukemia, lymphoma, and myeloma. The primary diagnostic methods for hematologic diseases include complete blood counts, peripheral smears, and bone marrow examinations. The selection of these tests is based on the patient's symptoms, physical examination findings, and the preliminary diagnoses made by the physician. An incorrect diagnostic approach by the physician can result in misdiagnosis and improper treatment, emphasizing the importance of accurate and thorough diagnostic processes. Artificial intelligence (AI) is a field of science dedicated to creating computer systems that possess human-like intelligence. Within AI, machine learning is a branch that enables computer systems to learn from data and gain experience. Deep learning, a subset of machine learning, utilizes multi-layered artificial neural networks to process large and complex datasets. Computer vision is another domain within AI that allows computers to analyze, understand, and interpret visual data from images and videos. With the continuous advancement of technology, AI has begun to play a significant role in the medical field. AI algorithms, such as those based on machine learning, deep learning, and computer vision, are increasingly being utilized in the diagnosis and treatment of diseases. For instance, these AI algorithms can analyze complete blood counts, peripheral smears, and bone marrow examinations to aid in the diagnosis and treatment of hematologic conditions. The success of these AI algorithms depends on the type of disease being tested and the adequacy of the training dataset. [ABSTRACT FROM AUTHOR]

An interview with Dr. Jamie Colbert, chief medical officer at Memora Health, is presented, about a conversational AI chatbot created by Memora Health. Dr. Colbert discusses the platform's goal regarding prep for gastrointestinal (GI) procedures, how Memora's conversational AI can improve patient care, and how Memora has been used to improve colonoscopy procedures.

Jordanian healthcare institutes have launched several programs since 2009 to establish health information systems (HISs). Nowadays, the generic expectation is that the use of HIS resources is performed on daily basis among healthcare staff. However, there can be still a noticeable barrier due to a lack of knowledge if medical doctors do not receive proper training on existing HISs. Moreover, the lack of studies on this area hinders the clarity about the received versus the required training skills among medical doctors. To support this research initiative, survey data have been collected from specialized medical doctors who are currently affiliated with five Jordanian universities to assess their need for HIS training. The results also aim to explore the extent of medical doctors’ use of HIS resources in Jordan. Moreover, they examine whether medical doctors require additional training on using HIS resources or not, as well as the main areas of required training programs. Specifically, this paper highlights the main topics that can be suitable subjects for enhanced training programs. The results show that most respondents use HISs in their daily clinical practices. However, most of them have not taken professional training on such systems. Hence, most of the respondents reported the need for additional training programs on several aspects of HIS resources. Moreover, based on the survey results, the most significant areas that require training are biomedical data analysis, artificial intelligence in medicine, health care management, and recent advances in electronic health records, respectively. Therefore, specialized medical doctors in Jordan need training on extracting useful and potential features of HISs. Education and training professionals in healthcare are recommended to establish training programs in Jordanian healthcare centers, which can further improve the quality of healthcare.

Despite its exponential growth, artificial intelligence (AI) in healthcare faces various challenges. One of them is a lack of explainability of AI medical devices, which arguably leads to insufficient trust in AI technologies, quality, and accountability and liability issues. The aim of this paper is to examine whether, why and to what extent AI explainability should be demanded with relation to AI-enabled medical devices and their outputs. Relying on a critical analysis of interdisciplinary literature on this topic and an empirical study, we conclude that the role of AI explainability in the medical AI context is a limited one. If narrowly defined, AI explainability principle is capable of addressing only a limited range of challenges associated with AI and is likely to reach fewer goals than sometimes expected. The study shows that, instead of technical explainability of medical AI devices, most stakeholders need more transparency around its development and quality assurance process. [ABSTRACT FROM AUTHOR]

Previous academic research reveals that mean-variance asset pricing (MVAP) models such as the single-period capital asset pricing model (CAPM) fail to produce rational European option prices. This article shows two adaptations of MVAP models that may be used to value derivatives with nonlinear payouts. The first removes static option arbitrage in investors' optimized aggregate portfolio selection. The second linearizes the pricing kernel, using a static version of the self-financing condition applied in dynamic option modeling. Both adaptations produce risk-neutral derivative prices in equilibrium for all finite-moment probability distributions of underlying asset prices with compact support. The derivation does not require stochastic calculus, frictionless continuous trading assumptions, or the solution of differential equations. The resulting model is a hybrid of equilibrium and arbitrage techniques that rationally values assets and derivatives. [ABSTRACT FROM AUTHOR]

Inflammatory bowel disease (IBD), with its 2 subtypes, Crohn's disease and ulcerative colitis, is a complex chronic condition. A precise definition of disease activity and appropriate drug management greatly improve the clinical course while minimizing the risk or cost. Artificial intelligence (AI) has been used in several medical diseases or situations. Herein, we provide an overview of AI for endoscopy in IBD. We discuss how AI can improve clinical practice and how some components have already begun to shape our knowledge. There may be a time when we can use AI in clinical practice. As AI systems contribute to the exact diagnosis and treatment of human disease, we should continue to learn best practices in health care in the field of IBD. [ABSTRACT FROM AUTHOR]

Background: Similar to understanding how blood pressure is measured by a sphygmomanometer, physicians will soon have to understand how an artificial intelligence–based application has come to the conclusion that a patient has hypertension, diabetes, or cancer. Although there are an increasing number of use cases where artificial intelligence is or can be applied to improve medical outcomes, the extent to which medical doctors and students are ready to work and leverage this paradigm is unclear. Objective: This research aims to capture medical students’ and doctors’ level of familiarity toward artificial intelligence in medicine as well as their challenges, barriers, and potential risks linked to the democratization of this new paradigm. Methods: A web-based questionnaire comprising five dimensions—demographics, concepts and definitions, training and education, implementation, and risks—was systematically designed from a literature search. It was completed by 207 participants in total, of which 105 (50.7%) medical doctors and 102 (49.3%) medical students trained in all continents, with most of them in Europe, the Middle East, Asia, and North America. Results: The results revealed no significant difference in the familiarity of artificial intelligence between medical doctors and students (P=.91), except that medical students perceived artificial intelligence in medicine to lead to higher risks for patients and the field of medicine in general (P<.001). We also identified a rather low level of familiarity with artificial intelligence (medical students=2.11/5; medical doctors=2.06/5) as well as a low attendance to education or training. Only 2.9% (3/105) of medical doctors attended a course on artificial intelligence within the previous year, compared with 9.8% (10/102) of medical students. The complexity of the field of medicine was considered one of the biggest challenges (medical doctors=3.5/5; medical students=3.8/5), whereas the reduction of physicians’skills was the most important risk (medical doctors=3.3; medical students=3.6; P=.03). Conclusions: The question is not whether artificial intelligence will be used in medicine, but when it will become a standard practice for optimizing health care. The low level of familiarity with artificial intelligence identified in this study calls for the implementation of specific education and training in medical schools and hospitals to ensure that medical professionals can leverage this new paradigm and improve health outcomes. [ABSTRACT FROM AUTHOR]

Artificial Intellegence is an assemblage of many algorithms for analysing and interpreting knowledge from vast collection of heterogenous data, which influenced a wide range of indusries. The concepts of AI are related to fields like statistics, probability, pattern recognition, machie learning etc. collectively called as “computational intelligence”. This paper analyses the impact of these techinques in the healthcare life cycle starting from diagnosis to treatment and also its contribution in prevention. As a small error in the applicability will lead to dangeous and ireversible effect, this paper analyses the means by which governments taking care of and ensuring their performance while giving permission for the products based on AI in healthcare. [ABSTRACT FROM AUTHOR]